At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...